This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 2Negative Pressure Ventilation
- 1Cellular versus Acellular
- 1Custom-designed platforms
- 1EVLP
- 1Ex Vivo Lung Perfusion
- 1Ex-Situ Lung Perfusion
-
Spring 2019
Lung transplantation is a life-saving therapy for patients suffering from end-stage lung disease; however, there exists a discrepancy between suitable donor grafts and utilization rates. At most, only 40% of offered donor lungs are utilized for transplantation. The majority are deemed...
-
Fall 2023
Lung transplantation is the gold-standard treatment for eligible patients with end-stage lung disease; however, there is an inadequate supply of high-quality donor lungs for transplant, resulting in a wait-list mortality of 15-30%. Ex-situ Lung Perfusion (ESLP) has become an established means of...